ELIMINATION KINETICS OF CAPTOPRIL IN PATIENTS WITH RENAL-FAILURE
ELIMINATION KINETICS OF CAPTOPRIL IN PATIENTS WITH RENAL-FAILURE
复制标题
DOI:
10.1038/ki.1984.114
复制
发表时间:
1984-01-01
影响因子:
19.6
通讯作者:
ROMMEL, AJ
中科院分区:
文献类型:
--
作者:
DUCHIN, KL;PIERIDES, AM;ROMMEL, AJ
Captopril kinetics were determined after a 100-mg oral dose of 14C-captopril in 21 patients with various degrees of renal impairment. Elimination kinetics of captopril were evaluated by model-independent methods. The body clearance (ClB) of captopril decreased steadily with decreasing creatinine clearance (ClCR) from 5.2 ml/min/kg for mild renal failure patients to 1.6 ml/min/kg for hemodialysis patients during an interdialytic period. In patients with mild renal impairment, renal and nonrenal clearances of captopril averaged 2.2 and 3.0 ml/min/kg, respectively, and fell (P < 0.001) to 0.2 and 1.5 ml/min/kg in patients with severe renal impairment. There were no significant differences in the extent of total cumulative excretion (fecal plus urinary) of radioactivity over a 96 to 120 h period between the patients with mild, moderate, and severe renal impairment. The 48 h renal excretion of captopril averaged 29, 21, and 8% of the dose in the mild, moderate, and severe renally impaired groups. In five additional hemodialysis patients, the mean dialyzer clearance of captopril averaged 120 ml/min. Of the dose, .apprx. 35% was recovered in the 4 h dialysate. A reduction in the dose of captopril may be necessary in patients with renal failure.